About SciGen Ltd
SciGen’s strategy is to focus on biosimilars (follow-on proteins) in order to minimize the risk of early stage product development. SciGen also collaborates with strategic partners and institutions in order to continuously fill & improve its pipeline.
SciGen also in-licenses and distributes pharmaceutical products and medical devices.
For in-licensing, visit http://www.bioton.pl/en/about/article/show/116